Ramoil Management, Ltd. Announces the Establishment of RAMO Bio-Med, Inc., a Wholly Owned Subsidiary
July 01 2014 - 09:00AM
Marketwired
Ramoil Management, Ltd. Announces the Establishment of RAMO
Bio-Med, Inc., a Wholly Owned Subsidiary
LAS VEGAS, NV--(Marketwired - Jul 1, 2014) - RAMOIL MANAGEMENT,
Ltd (OTC-PINK: RAMO) (PINKSHEETS: RAMO), announces today that it
has filed and established RAMO Bio-Med, Inc., a Florida wholly
owned subsidiary, as the operating entity of and for the
"Supercritical CO2 Molecular Extraction" technology and facilities
announced in the June 30th, 2014 Press Release.
Michael Goeree, the Company's Chairman, President and Chief
Executive Officer, said: "Today is a great day, when Ramoil
Management, Ltd. begins to establish a clear business model, with
proven technologies in a strong and growing business
sector. This is but one puzzle piece in an ever evolving
picture."
Mr. Goeree further states, "We can now produce our own bio-mass,
oil based, extracted products and concentrates, which allows us to
control quality from the raw material, through production to the
finished products and thus remain consistent through product and
market sales and placements. In this, we will also be afforded
the opportunity to conduct extensive research of and on all forms
of bio-masses."
The Company's present wholesale product lines can be reviewed at
www.ramocorp.com. A new webpage is under development to
represent the expansion and addition of our new wholly owned
subsidiary RAMO Bio-Med, Inc. All vapor oil and other plant based
products are expects to completed and ready for market by late
August, 2014.
RAMO Bio-Med, Inc.'s initial market, since it is a Florida
corporation, will be Florida, given that we are clearly eying all
recent Florida developments and opportunities. To this end,
the California and Nevada markets will be developed almost
simultaneously with Florida or ever so slightly thereafter.
About Ramoil Management, Ltd. Ramoil Management, Ltd. (RAMO) is
a development stage company. The Company is an online
wholesaler of E-cigarettes containing nutraceutical vapor oils,
E-cigarette delivery systems and hydroponic lighting and
nutrients.
About RAMO Bio-Med, Inc. RAMO Bio-Med, Inc. is a wholly owned
subsidiary of Ramoil Management, Ltd. (RAMO) and is a development
stage company. The Company is the operating company of the
newly acquired "Supercritical CO2 Molecular Extraction Technology"
and will be building operating production facilities and research
labs, both domestically and internationally.
Forward Looking Statements: This news release contains
forward-looking statements made by RAMOIL MANAGEMENT, LTD. All such
statements included in this press release, other than statements of
historical fact, are forward-looking statements. Although
management believes that the expectations reflected in such
forward-looking statements are reasonable, it can give no assurance
that such expectations will prove to have been correct. Actual
results may differ materially from those indicated by these
statements. The following risk factors, among others, could cause
actual results to differ materially from those described in any
forward-looking statements. These risks and uncertainties include,
but are not limited to, economic conditions, changes in the law or
regulations, demand for products of the Company, the effects of
competition and other factors that could cause actual results to
differ materially from those projected or represented in the
forward looking statements. Forward-looking statements are
typically identified by the words: believe, expect, anticipate,
intend, estimate, and similar expressions or which by their nature
refer to future events. The Company is not entitled to rely on
the safe harbor provisions of Section 27A of the Securities Act of
1933 and Section 21E of the Securities Exchange Act of 1934 because
it is not registered under either Act.
CONTACT: Company and Investor Relations Contact: Frank Blainey,
Esq. at: +1-702-381-1961
Ramoilir@gmail.com
Advantis (CE) (USOTC:ADVT)
Historical Stock Chart
From Feb 2024 to Mar 2024
Advantis (CE) (USOTC:ADVT)
Historical Stock Chart
From Mar 2023 to Mar 2024